fipexide has been researched along with Cognition Disorders in 1 studies
fipexide: regulates dopaminergic systems at macromolecular level
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty geriatric in-patients with severe cognition disorders were randomly allocated to treatment with either 600 mg fipexide daily or placebo over a period of 3 weeks." | 5.06 | Fipexide, an effective cognition activator in the elderly: a placebo-controlled, double-blind clinical trial. ( Bompani, R; Scali, G, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bompani, R | 1 |
| Scali, G | 1 |
1 trial available for fipexide and Cognition Disorders
| Article | Year |
|---|---|
Fipexide, an effective cognition activator in the elderly: a placebo-controlled, double-blind clinical trial.
Topics: Aged; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Cognition; Cognition Disorders; Doubl | 1986 |